Shire PLC Company Profile (NASDAQ:SHPG)

About Shire PLC

Shire PLC logoShire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. The Company's products include VYVANSE/VENVANSE/ELVANSE/TYVENSE/ELVANSEVUXEN/ADUVANZ (lisdexamfetamine dimesylate), ADDERALL XR (mixed salts of a single-entity amphetamine), INTUNIV (extended release guanfacine), LIALDA (mesalamine)/MEZAVANT(mesalazine), PENTASA (mesalamine), REPLAGAL (agalsidase alfa), ELAPRASE (idursulfase), VPRIV (velaglucerase alfa), FIRAZYR (icatibant), FOSRENOL (lanthanum carbonate), KALBITOR, CINRYZE C1 esterase inhibitor (human), GATTEX/REVESTIVE, BUMINATE 25% Albumin (Human), BUMINATE 5% Albumin (Human), GLASSIA Alpha1-Proteinase Inhibitor (Human) and ONCASPAR pegaspargase.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: SHPG
  • CUSIP:
Key Metrics:
  • Previous Close: $203.05
  • 50 Day Moving Average: $196.29
  • 200 Day Moving Average: $184.42
  • 52-Week Range: $147.60 - $231.32
  • Trailing P/E Ratio: 42.20
  • Foreward P/E Ratio: 13.31
  • P/E Growth: 1.11
  • Market Cap: $60.48B
  • Outstanding Shares: 297,854,000
  • Beta: 1.11
  • Net Margins: 13.19%
  • Return on Equity: 17.70%
  • Return on Assets: 8.17%
  • Debt-to-Equity Ratio: 0.72%
  • Current Ratio: 1.41%
  • Quick Ratio: 0.56%
Additional Links:
Companies Related to Shire PLC:

Analyst Ratings

Consensus Ratings for Shire PLC (NASDAQ:SHPG) (?)
Ratings Breakdown: 2 Hold Ratings, 23 Buy Ratings
Consensus Rating:Buy (Score: 2.92)
Consensus Price Target: $232.56 (14.53% upside)

Analysts' Ratings History for Shire PLC (NASDAQ:SHPG)
DateFirmActionRatingPrice TargetDetails
9/20/2016Jefferies GroupReiterated RatingBuy$262.00View Rating Details
9/19/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
8/30/2016Shore CapitalReiterated RatingBuyView Rating Details
8/3/2016RBC Capital MarketsReiterated RatingOutperformView Rating Details
8/3/2016Leerink SwannReiterated RatingOutperform$213.00 -> $231.00View Rating Details
8/3/2016GuggenheimReiterated RatingNeutralView Rating Details
8/1/2016JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details
7/15/2016Piper Jaffray Cos.Reiterated RatingNeutral$174.00View Rating Details
7/12/2016BTIG ResearchReiterated RatingBuy$230.00View Rating Details
6/28/2016Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details
6/15/2016Royal Bank Of CanadaReiterated RatingOutperformView Rating Details
6/9/2016Sanford C. BernsteinReiterated RatingOutperform$222.00View Rating Details
6/3/2016Morgan StanleyReiterated RatingOverweightView Rating Details
5/26/2016Stifel NicolausInitiated CoverageBuy$230.00View Rating Details
5/23/2016Bryan, Garnier & CoInitiated CoverageBuyView Rating Details
5/6/2016Liberum CapitalInitiated CoverageBuyView Rating Details
5/3/2016Cowen and CompanyReiterated RatingBuyView Rating Details
3/30/2016Bank of America Corp.Reiterated RatingBuyView Rating Details
2/26/2016Cantor FitzgeraldInitiated CoverageBuyView Rating Details
2/13/2016Northland SecuritiesReiterated RatingBuyView Rating Details
2/8/2016SusquehannaLower Price TargetPositive$280.00 -> $220.00View Rating Details
1/18/2016Credit Suisse Group AGUpgradeBuyView Rating Details
1/18/2016BNP ParibasUpgradeNeutral -> OutperformView Rating Details
11/3/2015HSBCUpgradeHold -> BuyView Rating Details
10/21/2015William BlairReiterated RatingOutperform$276.00View Rating Details
9/21/2015Barclays PLCUpgradeEqual Weight -> OverweightView Rating Details
7/16/2015Berenberg BankInitiated CoverageBuyView Rating Details
6/8/2015Deutsche Bank AGReiterated RatingBuyView Rating Details
5/6/2015Kepler Capital MarketsReiterated RatingBuyView Rating Details
1/12/2015S&P Equity ResearchDowngradeStrong-Buy -> BuyView Rating Details
1/5/2015Panmure GordonReiterated RatingBuyView Rating Details
10/27/2014CRT CapitalReiterated RatingBuy$225.00 -> $233.00View Rating Details
10/20/2014SunTrust Banks Inc.UpgradeNeutral -> Buy$269.00 -> $225.00View Rating Details
(Data available from 9/25/2014 forward)


Earnings History for Shire PLC (NASDAQ:SHPG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2016Q216$3.03$3.38$2.28 billion$2.43 millionViewN/AView Earnings Details
4/29/2016Q1$3.05$3.19$1.71 billion$1.71 billionViewListenView Earnings Details
2/11/2016Q415$2.89$2.97$1.69 million$1.72 billionViewListenView Earnings Details
10/23/2015Q315$2.87$3.24$1.63 billion$1.58 billionViewListenView Earnings Details
7/23/2015Q215$2.81$2.63$1.59 billion$1.56 billionViewListenView Earnings Details
4/30/2015Q115$2.56$2.84$1.47 billion$1.49 billionViewN/AView Earnings Details
2/12/2015Q115$2.68$2.63$1.58 billionViewN/AView Earnings Details
10/24/2014Q314$2.47$2.93$1.46 billion$1.55 billionViewListenView Earnings Details
7/18/2014Q214$2.45$2.67$1.45 billion$1.50 billionViewN/AView Earnings Details
5/1/2014Q114$2.22$2.36$1.38 billion$1.35 billionViewN/AView Earnings Details
2/13/2014Q413$2.02$2.26$1.28 billion$1.33 billionViewN/AView Earnings Details
10/24/2013Q213$1.65$1.77$1.23 billion$1.24 billionViewN/AView Earnings Details
7/25/2013$1.60$1.79$1.21 billion$1.28 billionViewN/AView Earnings Details
5/2/2013Q113$1.56$1.63$1.21 billion$1.16 billionViewN/AView Earnings Details
2/14/2013Q412$1.58$1.58$1.20 billion$1.20 billionViewN/AView Earnings Details
10/25/2012$1.47$1.36ViewN/AView Earnings Details
8/1/2012$1.52$1.68ViewN/AView Earnings Details
4/26/2012$0.52$1.24ViewN/AView Earnings Details
2/9/2012$0.48$0.44ViewN/AView Earnings Details
10/28/2011$1.31$1.28ViewN/AView Earnings Details
7/28/2011$1.24$1.33ViewN/AView Earnings Details
4/28/2011$1.18$1.23ViewN/AView Earnings Details
2/10/2011$1.04$1.03ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Shire PLC (NASDAQ:SHPG)
Current Year EPS Consensus Estimate: $13 EPS
Next Year EPS Consensus Estimate: $15.25 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20167$2.76$3.17$3.01
Q2 20164$3.05$3.23$3.13
Q3 20164$3.00$3.43$3.14
Q4 20164$3.02$3.68$3.31
(Data provided by Zacks Investment Research)


Current Dividend Information for Shire PLC (NASDAQ:SHPG)
Annual Dividend:$0.80
Dividend Yield:0.39%
Payout Ratio:15.63% (Based on Trailing 12 Months of Earnings)
6.15% (Based on Current Year Consensus EPS Estimate)
5.25% (Based on Next Year Consensus EPS Estimate)

Dividend History for Shire PLC (NASDAQ:SHPG)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Shire PLC (NASDAQ:SHPG)
No insider trades for this company have been tracked by


Latest Headlines for Shire PLC (NASDAQ:SHPG)
DateHeadline logoAmgen, Biogen Pitted In M&A Scenario; Adamas, Acadia Draw Interest (NASDAQ:SHPG) - September 23 at 6:43 PM
News IconDrug Manufacturers – Major: Shire plc (NASDAQ:SHPG) Position of the day (NASDAQ:SHPG) - September 23 at 11:57 AM logoShire to Showcase Continued Innovation and Leadership in Immune Deficiencies During European Society for Immunodeficiencies Biennial Meeting (NASDAQ:SHPG) - September 23 at 11:57 AM logoSHIRE TO SHOWCASE CONTINUED ... (NASDAQ:SHPG) - September 23 at 11:57 AM logoShire Closes Public Offering of Senior Notes (NASDAQ:SHPG) - September 23 at 11:57 AM logoSHIRE PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation o (NASDAQ:SHPG) - September 23 at 11:57 AM logoShire Closes Public Offering of ... (NASDAQ:SHPG) - September 23 at 11:57 AM
News IconUpcoming Earnings Report: Shire plc (NASDAQ:SHPG) - The Voice Registrar (NASDAQ:SHPG) - September 22 at 6:56 PM
News IconAnalyst Reviews: Shire plc (SHPG) - (NASDAQ:SHPG) - September 22 at 12:05 PM
News IconShire plc (NASDAQ:SHPG) from Drug Manufacturers – Major – Todays Top Gains - Twin County News (NASDAQ:SHPG) - September 22 at 12:05 PM logo​The bobble-head doll in the office of Shire CEO Flemming Ornskov (NASDAQ:SHPG) - September 22 at 12:05 PM logoShire : Files 8K - Entry Into Definitive Agreement (NASDAQ:SHPG) - September 21 at 6:52 PM
News IconLeading stocks in today’s market: Shire plc (NASDAQ:SHPG) (NASDAQ:SHPG) - September 21 at 6:52 PM logoCorporations Have Been Issuing Larger Bonds (BUD, SHPG) (NASDAQ:SHPG) - September 21 at 6:52 PM logoShire cools to pacritinib, intends to return to CTI Biopharma (NASDAQ:SHPG) - September 21 at 11:22 AM logoShire Prices Public Offering of Senior Notes (NASDAQ:SHPG) - September 20 at 12:37 PM
News IconLONDON MARKETS: FTSE 100 Climbs As Pound Drops To Lowest In More Than A Month (NASDAQ:SHPG) - September 20 at 12:37 PM logoShire Prices Public Offering Of Senior Notes - Quick Facts (NASDAQ:SHPG) - September 20 at 12:37 PM logoJefferies Believes Xiidra To Bring More Business To Shire PLC (ADR) (SHPG) Than Expected (NASDAQ:SHPG) - September 20 at 12:37 PM logoShire prices $12B debt offering (NASDAQ:SHPG) - September 20 at 12:37 PM
News IconNews Review: Shire PLC (ADR)(NASDAQ:SHPG), Abercrombie & Fitch Co.(NYSE:ANF), BioMarin Pharmaceutical Inc ... - NYSE Journal (press release) (NASDAQ:SHPG) - September 19 at 7:13 PM logoHIGHGRADE CLOSE-Five high-grade issuers raise US$15.614bn (NASDAQ:SHPG) - September 19 at 7:13 PM
News IconUpbeat Stocks in Focus- Shire plc (NASDAQ:SHPG), Dominion Resources, Inc. (NYSE:D), ContraFect Corporation ... - Seneca Globe (NASDAQ:SHPG) - September 19 at 11:51 AM logoSHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits (NASDAQ:SHPG) - September 19 at 11:51 AM logoCourt rules against Shire in Lialda patent infringement case (NASDAQ:SHPG) - September 18 at 11:28 AM logo4:56 pm Shire plc confirmed District Court issues ruling in Hatch Waxman case regarding Shire's LIALDA; to consider appeal (NASDAQ:SHPG) - September 18 at 11:28 AM
News IconDistrict Court Issues Ruling in Hatch Waxman Case Regarding Shire's LIALDA® (NASDAQ:SHPG) - September 16 at 7:00 PM
News IconIs Shire plc (NASDAQ:SHPG), a large market cap stock a smart buy? (NASDAQ:SHPG) - September 16 at 7:00 PM logoDistrict Court Issues Ruling in ... (NASDAQ:SHPG) - September 16 at 7:00 PM logoFDA OKs another Shire immunoglobulin - Seeking Alpha (NASDAQ:SHPG) - September 15 at 10:56 AM
News IconActive Momentum Stocks in New Buzz: Shire plc (NASDAQ:SHPG), Infosys (NYSE:INFY), Ambev S.A. (NYSE:ABEV) - Street Wise Report (press release) (blog) (NASDAQ:SHPG) - September 15 at 10:56 AM logoShire's Immunodeficiency Treatment Cuvitru Gets FDA Approval (NASDAQ:SHPG) - September 15 at 10:56 AM logoShire Announces U.S. FDA Approval of CUVITRU Treatment for Primary Immunodeficiency (NASDAQ:SHPG) - September 14 at 11:41 AM logoShire (SHPG) Receives FDA Approval for CUVITRU as Primary Immunodeficiency Treatment (NASDAQ:SHPG) - September 14 at 11:41 AM logoShire Gets FDA Approval For Cuvitru To Treat Immunodeficiency (NASDAQ:SHPG) - September 14 at 11:41 AM logoFDA OKs another Shire immunoglobulin (NASDAQ:SHPG) - September 14 at 11:41 AM logoShire announces U.S. FDA approval of ... (NASDAQ:SHPG) - September 14 at 11:41 AM logoShire's treatment for primary immunodeficiency wins FDA approval (NASDAQ:SHPG) - September 14 at 11:41 AM
News IconIs Shire plc(NASDAQ: SHPG), a large market cap stock a smart buy ... - The Daily Leicester (NASDAQ:SHPG) - September 10 at 11:29 AM
News IconLong Term Growth Stock in Review: Shire plc (NASDAQ:SHPG) - National Daily Press (NASDAQ:SHPG) - September 9 at 12:04 PM logoEx-Dividend Reminder: Anthem, Becton, Dickinson and and Shire - Forbes (NASDAQ:SHPG) - September 8 at 11:07 AM logoShire to Participate at Two Upcoming Investor Conferences (NASDAQ:SHPG) - September 8 at 11:07 AM logoShire to participate at two upcoming ... (NASDAQ:SHPG) - September 8 at 11:07 AM
News IconStock Gapping Down Before the Bell: Shire plc (NASDAQ:SHPG) - Post News (NASDAQ:SHPG) - September 7 at 7:25 PM logoShire to roadshow benchmark US dollar bond Sept 12-15: Source (NASDAQ:SHPG) - September 7 at 11:00 AM logoEx-Dividend Reminder: Anthem, Becton, Dickinson and and Shire (NASDAQ:SHPG) - September 6 at 12:01 PM logoU.S. Securities and Exchange Commission filings (NASDAQ:SHPG) - September 5 at 11:22 AM logoAccounts Payable For Shire plc (NASDAQ:SHPG) Is $3728.1 - (NASDAQ:SHPG) - September 4 at 11:15 AM logoShire plc: U.S. Securities and Exchange Commission Filings (NASDAQ:SHPG) - September 2 at 7:12 PM logoU.S. Securities and Exchange Commission ... (NASDAQ:SHPG) - September 2 at 7:12 PM


Shire PLC (NASDAQ:SHPG) Chart for Sunday, September, 25, 2016

Last Updated on 9/25/2016 by Staff